doi: 10.1038/sj.ijo.0801083 Summary Keywords Prader-Willi syndrome, obesity, GLP-1 receptor agonist, semaglutide, metabolic surgery Citation Koceva A, Mleku Kozamernik K, Jane A, Herman R, Ferjan S and Jensterle M (2025) Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
Microdosing Semaglutide Split dosing strategies for better tolerability
Important Disclosures: Carriers are not liable for delayed or undelivered messages
Malkin SJP, Hunt B, Huisman EL, Grand TS, Chubb B
The hypothalamic-pituitary-ovarian axis, which governs reproductive function, is sensitive to energy availability